Christopher Miller, PhD

Medical School Department Internal Medicine
Research Program Hematopoietic Development & Malignancy
Christopher Miller

Researcher Background

Primary Academic Title

Associate Professor of Medicine, Division of Oncology, WashU Medicine

Education

  • 2011: PhD, Baylor College of Medicine, Houston, TX

Research & Selected Publications

Research Interest

Developing and applying genomic and bioinformatic technologies to understand the origins of cancer

Research Publications

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.
Authors:

Garfinkle EAR, Perales-Linares R, Gimple RC, one or more additional authors omitted Miller CA, one or more additional authors omitted Johanns TM

Journal & Year:

Nat Cancer • 2026

Overexpression of the signaling coordinator GAB2 can play an important role in acute myeloid leukemia progression.
Authors:

Kramer MH, Richardson SN, Li Y, one or more additional authors omitted Miller CA, Ley TJ

Journal & Year:

J Clin Invest • 2025

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response.
Authors:

Jacoby MA, Duncavage ED, Khanna A, one or more additional authors omitted Miller CA, one or more additional authors omitted Walter MJ

Journal & Year:

Leukemia • 2025

pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection.
Authors:

Xia H, Hoang MH, Schmidt E, one or more additional authors omitted Miller CA, one or more additional authors omitted Griffith M

Journal & Year:

Genome Med • 2024

Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
Authors:

Zhang X, Goedegebuure SP, Chen MY, one or more additional authors omitted Miller CA, one or more additional authors omitted Gillanders WE

Journal & Year:

Genome Med • 2024

Rapid and accurate remethylation of DNA in Dnmt3a-deficient hematopoietic cells with restoration of DNMT3A activity.
Authors:

Li Y, Abel HJ, Cai M, one or more additional authors omitted Miller CA, Ley TJ

Journal & Year:

Sci Adv • 2024

Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein.
Authors:

Day RB, Hickman JA, Xu Z, one or more additional authors omitted Miller CA, Ley TJ

Journal & Year:

J Clin Invest • 2023